ALPS Advisors’s Vor Biopharma VOR Stock Holding History

ALPS Advisors’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	+54,998	New	+$832K	﹤0.01%	699

Other funds holding VOR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FRM

Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

ALPS Advisors's VOR Position: Q2 2026 in Review

ALPS Advisors opened a new position in Vor Biopharma (VOR) in Q2 2026: 54,998 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #699 among its holdings.

25 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

ALPS Advisors held 54,998 shares of Vor Biopharma worth $1.01M as of Q2 2026.
Vor Biopharma was a new ALPS Advisors position in Q2 2026.
Vor Biopharma made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #699 holding.
25 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.